Sanofi to buy US Synthorx for $2.5B
French pharmaceutical giant Sanofi said it agreed to pay $2.5 billion in cash for California-based biotechnology firm Synthorx. Shareholders of Synthorx will receive $68 per share they own, a 172% premium closing price on December 6. The parties expect the deal to close in first quarter of next year. Sanofi will merge with Synthorx following […]
